文献速递糖尿病

2000-2016年美国印第安人与阿拉斯加原住民、黑人和西班牙裔的糖尿病相关终末期肾病发病率持续较低

Sustained Lower Incidence of Diabetes-Related End-Stage Kidney Disease Among American Indians and Alaska Natives, Blacks, and Hispanics in the U.S., 2000-2016.
PubMed 文献 · Diabetes Care · 2020-07-02

该研究利用美国肾脏数据系统2000-2016年数据,分析成人新治疗糖尿病相关终末期肾病(ESKD-D)的发病率趋势。结果显示,印第安人与阿拉斯加原住民、西班牙裔和黑人的年龄调整ESKD-D发病率分别下降53%、33%和20%,而白人上升10%,亚裔无显著变化。2016年这三个少数族裔的发病率仍约为白人的2.0-2.5倍。

要点

  • 2000-2016年,印第安人与阿拉斯加原住民ESKD-D发病率下降53%,西班牙裔下降33%,黑人下降20%。
  • 同期白人ESKD-D发病率上升10%,亚裔无显著变化。
  • 2016年,印第安人与阿拉斯加原住民、西班牙裔和黑人的ESKD-D发病率约为白人的2.0-2.5倍。

核心结论

  • 印第安人与阿拉斯加原住民、西班牙裔和黑人的ESKD-D发病率下降,而白人上升。
  • 作者认为可考虑持续努力以扭转白人趋势并维持和降低其他人群的ESKD-D发病率。

研究设计与样本

  • 研究使用美国肾脏数据系统2000-2016年数据,纳入年龄≥18岁、新治疗且糖尿病列为主要原因的ESKD-D患者,涵盖白人、黑人、印第安人与阿拉斯加原住民、亚裔和西班牙裔。
  • 以人口普查估计数为分母计算年发病率,并按2000年美国标准人口进行年龄调整,采用Joinpoint回归分析趋势并估算平均年度百分比变化(AAPC)。

主要发现

  • 2000-2016年,年龄调整ESKD-D发病率在印第安人与阿拉斯加原住民中从每10万人66.7降至31.2,下降53%(AAPC -4.5%,P < 0.001)。
  • 西班牙裔从50.0降至33.3,下降33%(AAPC -2.1%,P < 0.001);黑人从56.2降至44.7,下降20%(AAPC -1.6%,P < 0.001)。
  • 白人从15.4升至17.0,上升10%(AAPC 0.6%,P = 0.01);亚裔发病率无显著变化。
  • 2016年,印第安人与阿拉斯加原住民、西班牙裔和黑人的ESKD-D发病率约为白人的2.0-2.5倍。

临床怎么用

  • 作者认为可考虑持续努力以扭转白人ESKD-D发病率上升趋势,并维持和降低其他人群的发病率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Diabetes-related end-stage kidney disease (ESKD-D) disproportionately affects U.S. racial/ethnic minority populations compared with whites. However, from 1996 to 2013, ESKD-D incidence among American Indians and Alaska Natives (AIANs) and blacks declined. We assessed recent ESKD-D incidence data to determine whether trends by race/ethnicity have changed since 2013. RESEARCH DESIGN AND METHODS: United States Renal Data System data from 2000 to 2016 were used to determine the number of whites, blacks, AIANs, Asians, and Hispanics aged ≥18 years with newly treated ESKD-D (with diabetes listed as primary cause). Using census population estimates as denominators, annual ESKD-D incidence rates were calculated and age adjusted to the 2000 U.S. standard population. Joinpoint regression was used to analyze trends and estimate an average annual percent change (AAPC) in incidence rates. RESULTS: For adults overall, from 2000 to 2016, age-adjusted ESKD-D incidence rates decreased by 53% for AIANs (66.7-31.2 per 100,000, AAPC -4.5%, P < 0.001), by 33% for Hispanics (50.0-33.3, -2.1%, P < 0.001), and by 20% for blacks (56.2-44.7, -1.6%, P < 0.001). However, during the study period, age-adjusted ESKD-D incidence rates did not change significantly for Asians and increased by 10% for whites (15.4-17.0, 0.6%, P = 0.01). In 2016, ESKD-D incidence rates in AIANs, Hispanics, and blacks were ∼2.0-2.5 times higher than whites. CONCLUSIONS: ESKD-D incidence declined for AIANs, Hispanics, and blacks and increased for whites. Continued efforts might be considered to reverse the trend in whites and sustain and lower ESKD-D incidence in the other populations.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Burrows NR, Zhang Y, Hora I, et al. Sustained Lower Incidence of Diabetes-Related End-Stage Kidney Disease Among American Indians and Alaska Natives, Blacks, and Hispanics in the U.S., 2000-2016. Diabetes Care. 2020. PMID: 32616609. doi:10.2337/dc20-0495

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。